Owler

MAY 17, 2023

Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds. Plans for the funds include fortifying Ripplr’s tech platform for team expansion and building a pan-India presence. Everseen Raises $71.3M

Biotech 52

Biotech Travel Capital Entertainment 52

ArchIntel

MARCH 9, 2021

PharmaEssentia is looking for candidates with more than 10 years of experience in the pharma or biotech industry as a business insights, analytics and forecasting professional. The person selected for this position will be given the option to work remotely or join PharmaEssentia’s office in Burlington, Massachusetts.

Biotech 104

Biotech Pharmaceutical Travel Competitive Intelligence 104

Sedulo

MARCH 15, 2023

Key Takeaways from the Assessment: While several insights were uncovered by analyzing trial clusters and the different IO drug modalities and sponsors, a few key takeaways from the data included: China emerging as innovation hub for IO therapies Smaller pharma/biotech conducting trials for emerging IO technologies Chinese and US small pharma/biotech (..)

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Owler

JUNE 14, 2023

In Series A Funding Italy-based biotech company Aavantgarde Bio expressed that its initial focus following its successful funding round is to utilize the $65.3M The company automates home price estimate calculations using AI and manual assessments, allowing customers to sell their homes online and receive funds within 10 days.

Biotech 52

Biotech Startups Capital Research 52

Zoominfo

APRIL 2, 2020

to discuss the future of one of the world’s largest biotech companies. On February 26, 175 executives gathered at the Marriott Long Wharf hotel in Boston, Mass., Within days, it was revealed that several of them were infected with COVID-19.

Biotech 100

Biotech Business Human Resources Technology 100

Wink Intel

MARCH 29, 2021

Canadian firm buys Ohio National for $1 billion; Net income of life/annuity industry fell almost 50% in 2020; New index annuity income rider from AIG; SIMON adds First Trust Target Outcome ETFs; KKR, owner of Global Atlantic, reports earnings; Voya, Morningstar in managed accounts partnership; A ‘longevity’ biotech SPAC. .

Biotech 40

Biotech Globalization Management 40

Fuld

NOVEMBER 1, 2022

I plan to leverage that experience to help Fuld’s biotech and pharma clients successfully bring their own products to market. “Joining Fuld & Company is an exciting opportunity for me to work with global leaders in research, analytics, and intelligence ,” says Brad.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

IT Business Edge

JULY 12, 2022

In January, the company announced $9 billion in new capital for venture opportunities, growth stage and biotech. Andreessen Horowitz certainly has lots of fire power for many more deals. Lightspeed. Lightspeed got its start at the depths of the dotcom bust – October 2000. But the timing would be propitious.

Startups 101

Startups Capital Biotech Finance 101

Alpha Sense BI

AUGUST 30, 2023

Learn more about the AlphaSense impact by reading client success stories: DCAP Chooses AlphaSense for Faster, Deeper Searches—Saving Time and Money A fund with $50B in AUM starts all research with AlphaSense A biotech investor taps internal and external content for insights Get the Competitive Edge with AlphaSense AlphaSense is the leading market intelligence (..)

Management 98

Management Biotech Due Diligence Algorithm 98

Evalueserve

DECEMBER 6, 2021

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing.

Capital 98

Capital Globalization Biotech Marketing 98

Alpha Sense BI

MAY 5, 2023

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

ArchIntel

JUNE 9, 2021

Earlier in his career, Fields worked as a conference and marketing coordinator at EBD Group, an organizer of biotech and medical device events. Fields briefly served as a consultant for the UCLA Anderson School of Management while already employed at the telco.

Competitive 104

Competitive Competitive Intelligence Biotech Profiling 104

CIO

DECEMBER 27, 2023

Capital Bern is also quickly becoming a growing force, especially in the medtech, biotech, fintech, and cleantech industries, as the city has a longstanding reputation as being a hub for experts in healthcare, life sciences, and environmental sustainability.

Startups 860

Startups Biotech Capital Innovation 860

BIS Research

MARCH 19, 2019

As it has successfully managed to bring together its different segments such as pharmaceutical & biotech, diagnostics, healthcare IT companies, care providers, hospitals, physicians and patients.

Globalization 64

Globalization Biotech Marketing Marketing 64

Wink Intel

FEBRUARY 23, 2021

tech and biotech ETFs and two fixed income components. “By balancing risk and then seeking returns, this index aims to provide stable returns in many market environments.”. Credit Suisse Tech Edge Index (Ticker: CSEATEDG): The excess return index combines four U.S

Intellectual Property 40

Intellectual Property Biotech Banking Retail 40

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. billion.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

JANUARY 26, 2024

This renewed interest in rare disease therapeutics can be attributed to the U.S.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Alpha Sense BI

APRIL 12, 2024

For a healthcare engineer in the biotech engineering space, I’m gonna be really technical and get down to the nitty gritty behind the actual chemistry. You’re actually talking to the technologists, like the person building the code, the person selling the code, so you create different sets of questions depending on who the person is.” ”For

Primary Research 52

Primary Research Advantage Advantage Research 52

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He holds B.A. degrees in Neuroscience and Behavior, Genetics, and Economics from Columbia University.

Retail 52

Retail Capital Finance Biotech 52

CIO

JULY 17, 2023

It’s not only creating the vision but selling the vision,” says Joel Schwalbe, CIO of biotech company Transnetyx. “They need to create compelling rationalizations for IT investments through their storytelling. Tech governor in chief Such changes also will require CIOs to spend more time on governance, too, according to multiple sources.

Biotech 617

Biotech Innovation Technology Technology 617

Alpha Sense BI

NOVEMBER 9, 2022

M&A IPOs to watch in Pharma and Biotech. It’s going to help us to get it off the platform so that we could now invest in with the knowledge of what is working and replace those shows with content that has a chance to be more successful, have larger audiences, and we’re reallocating the capital.” – David M. JOYY Inc. [YY].

Sales 52

Sales Loss Capital Biotech 52

Alpha Sense BI

MARCH 4, 2024

.” – Associate Director, Pharmaceutical Company | Expert Transcript Identifying Drug Targets and Candidates Traditional methods are mostly based on singular hypothesis-driven approaches and are limited by human capacity to analyze multi-dimensional data, which means they are prone to human error and bias.

Biotech 52

Biotech Pharmaceutical Intelligence Intelligence 52

Alpha Sense BI

MARCH 13, 2024

According to an outlook published by PwC , “large-cap pharma companies are expected to continue pursuing mid-sized biotech companies to fill pipeline gaps in the face of impending patent cliffs. In January, Roche completed the $2.7

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

MARCH 28, 2023

The industries using expert networks the most are: information technology, industrials, media, healthcare , pharmaceutical, biotech, energy, consulting, asset management, hedge funds , private equity, venture capital, investment banking, and sell-side equity research. How do various industries benefit from expert networks? ​​

Value Chain 52

Value Chain Biotech Research Pharmaceutical 52

Happy Market

MAY 9, 2022

John Dick: I think we just touched on it a little bit, it was a little – times were a bit different, so when I – I sold my first company in March of 2007, and I had the sort of idea for CivicScience in my back pocket, it had been brewing for a while, and partly it was because of my first business, which was a completely different company. (..)

Management 52

Management Entertainment Market Research Marketing Research 52